Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.
The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.
Kessler Group Sky Garden London Nov 2018
- For Non-Scientists
- Research Overview
- Mass Spectrometry
- Public Engagement
- Photo Gallery
- Virtual tour of the Kessler Lab
- Former Group Members
Regulation of the endosomal SNX27-retromer by OTULIN
Stangl A. et al, (2019), Nature Communications, 10
BMP signaling inhibition in Drosophila secondary cells remodels the seminal proteome and self and rival ejaculate functions
Hopkins BR. et al, (2019), Proceedings of the National Academy of Sciences, 201914491 - 201914491
Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels.
Bagi Z. et al, (2019), Scientific reports, 9
Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
Vivas-García Y. et al, (2019), Molecular cell
PROTEOMICS REVEALS MOLECULAR WINDOW AND METABOLISM OF NORMOTHERMICALLY PERFUSED HUMAN KIDNEYS
Weissenbacher A. et al, (2019), TRANSPLANT INTERNATIONAL, 32, 26 - 26